Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03829020
Title Metformin and Nelfinavir in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic

multiple myeloma


Metformin + Nelfinavir

Bortezomib + Metformin + Nelfinavir

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.